STUB1 and neoplasm: By mining the repository of CRISPR screens (BioGRID ORCS)31, we realized that loss of Stub1 appears to reverse the resistance of immunotherapy in an in vivo tumour mouse model9 and enhance in vitro T cell-mediated killing of murine tumour cells, e.g., B16-F1010, CT2632 and Renca32.